Intensive Safety Monitoring of Rituximab (Biosimilar Novex® and the Innovator) in Pediatric Patients With Complex Diseases.
Riva N, Molina M, Cornaló BL, Salvador MV, Savransky A, Tenembaum S, Katsicas MM, Monteverde M, Cáceres Guido P, Rousseau M, Staciuk R, González Correas A, Zubizarreta P, Imventarza O, Lagomarsino E, Spitzer E, Tinelli M, Schaiquevich P.
Riva N, et al. Among authors: lagomarsino e.
Front Pharmacol. 2022 Jan 26;12:785770. doi: 10.3389/fphar.2021.785770. eCollection 2021.
Front Pharmacol. 2022.
PMID: 35153748
Free PMC article.